geranylgeraniol has been researched along with myristic acid in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barbieri, MA; Li, G; Stahl, PD | 1 |
Brenner, DA; Cox, AD; Der, CJ; Garcia, AM; Kowalczyk, JJ; Lewis, MD; Westwick, JK | 1 |
2 other study(ies) available for geranylgeraniol and myristic acid
Article | Year |
---|---|
Myristoylation cannot functionally replace the isoprenylation of Rab5.
Topics: Animals; Base Sequence; Biological Transport; Biomarkers; Cells, Cultured; Cricetinae; Diterpenes; Endocytosis; Gene Products, gag; GTP-Binding Proteins; Horseradish Peroxidase; Membranes; Molecular Sequence Data; Mutation; Myristic Acid; Myristic Acids; Protein Prenylation; Protein Processing, Post-Translational; rab5 GTP-Binding Proteins; Recombinant Fusion Proteins; Subcellular Fractions | 1995 |
The CAAX peptidomimetic compound B581 specifically blocks farnesylated, but not geranylgeranylated or myristylated, oncogenic ras signaling and transformation.
Topics: 3T3 Cells; Animals; Cell Transformation, Neoplastic; Diterpenes; DNA-Binding Proteins; ets-Domain Protein Elk-1; Farnesol; Mice; Myristic Acid; Myristic Acids; Oligopeptides; Oncogene Protein p21(ras); Protein Prenylation; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-jun; Retroviridae Proteins, Oncogenic; Signal Transduction; Transcription Factors; Transcription, Genetic | 1994 |